Advanced cancer models could help personalize lymphoma treatments

Advanced cancer models could help personalize lymphoma treatmentsby Nik Papageorgiou,Ecole Polytechnique Federale de LausanneLymphomoid spiral. Credit: Albert Santamaria-MartinezScientists at EP

Updated on: January 20,2025 0

Advanced cancer models could help personalize lymphoma treatments

Advanced cancer models could help personalize lymphoma treatmentsby Nik Papageorgiou,Ecole Polytechnique Federale de LausanneLymphomoid spiral. Credit: Albert Santamaria-MartinezScientists at EP

Updated on:January 20,2025 0

Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patients

Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patientsby NRG OncologyCredit: Pixabay/CC0 Public DomainRecent results from the Phase III NRG-RT

Updated on: January 21,2025 0

Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patients

Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patientsby NRG OncologyCredit: Pixabay/CC0 Public DomainRecent results from the Phase III NRG-RT

Updated on:January 21,2025 0

Microglia reprogramming offers novel strategy to combat melanoma brain metastases

Updated on: April 01,2025 0

Microglia reprogramming offers novel strategy to combat melanoma brain metastases

Updated on:April 01,2025 0

Proof-of-concept study bioengineers therapeutics for improved cancer treatment

by Children's Medical Research InstituteCredit: Pixabay/CC0 Public DomainA team of Children's Medical Research Institute (CMRI) scientists has identified a new method for producing a therapeut

Updated on: January 21,2025 0

Proof-of-concept study bioengineers therapeutics for improved cancer treatment

by Children's Medical Research InstituteCredit: Pixabay/CC0 Public DomainA team of Children's Medical Research Institute (CMRI) scientists has identified a new method for producing a therapeut

Updated on:January 21,2025 0

Research highlights urgent need for greater awareness to aid early diagnosis of bone cancers in young people

Updated on: April 01,2025 0

Research highlights urgent need for greater awareness to aid early diagnosis of bone cancers in young people

Updated on:April 01,2025 0

Menopausal status influences long-term benefit from anti-hormonal treatment, study shows

byKarolinska InstitutetCredit: Unsplash/CC0 Public DomainToday, women with estrogen-sensitive breast cancer receive anti-hormonal therapy. Researchers now show that postmenopausal women with low

Updated on: December 20,2024 0

Menopausal status influences long-term benefit from anti-hormonal treatment, study shows

byKarolinska InstitutetCredit: Unsplash/CC0 Public DomainToday, women with estrogen-sensitive breast cancer receive anti-hormonal therapy. Researchers now show that postmenopausal women with low

Updated on:December 20,2024 0

Predicting cardiac issues in cancer survivors using a serum protein panel test

bySt. Jude Children's Research HospitalUsing data from the St. Jude Lifetime Cohort (St. Jude LIFE), Yadav Sapkota, Ph.D., St. Jude Department of Epidemiology and Cancer Control, designed a

Updated on: December 20,2024 0

Predicting cardiac issues in cancer survivors using a serum protein panel test

bySt. Jude Children's Research HospitalUsing data from the St. Jude Lifetime Cohort (St. Jude LIFE), Yadav Sapkota, Ph.D., St. Jude Department of Epidemiology and Cancer Control, designed a

Updated on:December 20,2024 0

A step towards personalized immunotherapy: MIRO device replicates tumors, environments and interactions

Updated on: April 01,2025 0

A step towards personalized immunotherapy: MIRO device replicates tumors, environments and interactions

Updated on:April 01,2025 0

Even low levels of arsenic in drinking water raise kidney cancer risk, new study finds

by Ann Kellett,Texas A&M UniversityCredit: Unsplash/CC0 Public DomainNew research findings from the Texas A&M University School of Public Health indicate that exposure to even low levels

Updated on: December 20,2024 0

Even low levels of arsenic in drinking water raise kidney cancer risk, new study finds

by Ann Kellett,Texas A&M UniversityCredit: Unsplash/CC0 Public DomainNew research findings from the Texas A&M University School of Public Health indicate that exposure to even low levels

Updated on:December 20,2024 0

Putting the brakes on prostate cancer cells: Androgen receptor can alter normal prostate growth

by Alan Dove,Cornell UniversityA clump of prostate cancer cells. The blue-green cells are growing, whereas the pink ones are dying by programmed cell death (apoptosis). Credit: Dave McCarthy and

Updated on: January 23,2025 0

Putting the brakes on prostate cancer cells: Androgen receptor can alter normal prostate growth

by Alan Dove,Cornell UniversityA clump of prostate cancer cells. The blue-green cells are growing, whereas the pink ones are dying by programmed cell death (apoptosis). Credit: Dave McCarthy and

Updated on:January 23,2025 0

Study identifies 'turncoat' cells that fight—and aid—cancer

by Michael Masciadrelli,Yale UniversityCirculating tumor antigen reactive T cells in patients with advanced melanoma. Credit:Nature Immunology(2024). DOI: 10.1038/s41590-024-02023-4Y

Updated on: December 21,2024 0

Study identifies 'turncoat' cells that fight—and aid—cancer

by Michael Masciadrelli,Yale UniversityCirculating tumor antigen reactive T cells in patients with advanced melanoma. Credit:Nature Immunology(2024). DOI: 10.1038/s41590-024-02023-4Y

Updated on:December 21,2024 0

Study reveals immune-modulatory mechanism of lurbinectedin in small-cell lung cancer

byThe Mount Sinai HospitalLurbinectedin augments the anti-tumor immune response of PD-L1 blockade in immunocompetent SCLC models. Credit:Cell Reports Medicine(2024). DOI: 10.1016/j.x

Updated on: January 21,2025 0

Study reveals immune-modulatory mechanism of lurbinectedin in small-cell lung cancer

byThe Mount Sinai HospitalLurbinectedin augments the anti-tumor immune response of PD-L1 blockade in immunocompetent SCLC models. Credit:Cell Reports Medicine(2024). DOI: 10.1016/j.x

Updated on:January 21,2025 0